Psychopharmacology & Neuroscience Course: Update 2007 - Nov. 16 & 17
The purpose of this course is to provide a comprehensive update of recent clinical and preclinical advances in the drug treatment of mental disorders and is targeted toward practicing psychiatrists, senior residents, psychologists, and other mental health professionals.
The course objectives are threefold: to review preclinical concepts regarding the mechanism of action of psychopharmacologic agents, to present advances in clinical psychopharmacology including new drug development and new treatment approaches, and to integrate basic and clinical neuroscience into a comprehensive framework, which enables optimal clinical psychopharmacologic techniques.
The National Institutes of Health/Foundation for Advanced Education in the Sciences, Inc. (NIH/FAES) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The NIH/FAES designates this educational activity for a maximum of 12.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity
The National Institutes of Health (NIH) is approved by the American Psychological Association to offer continuing education for psychologists. The NIH maintains responsibility for the program. This academic course carries 12.5 CE credits.
